Janssen posts results of Phase 3 aticaprant study in major depressive disorder
Results for the VENTURA-LT study of aticaprant (JNJ-67953964) were first posted on October 6, 2026. The open-label, long-term safety and efficacy study enrolled 871 participants, started on September 22, 2022, and completed primary data collection on April 25, 2025.
Primary source
ClinicalTrials.gov results record, October 6, 2026
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
Read the source: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation